Clinical Trial Update: Mobile Application-delivered Resistance Program for Children and Adolescents With Type 1 Diabetes (Diactive-1) [NA]

View source ↗

Summary

Completed study evaluating a mobile app-delivered resistance program for children and adolescents with Type 1 Diabetes (Diactive-1).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Fundacion Miguel Servet | Conditions: Type 1 Diabetes | NA | Status: COMPLETED